Table-III.

Demographic and Laboratory data between Fazekas-0 and Fazekas-3 groups

	Fazekas-0 (n:34)	Fazekas-3 (n:34)	p
Age	66.22±8.55(52-76)	72.12±12.13(49-86)	0.001
Education (years)	7.43±6.11 (5-15)	5.91±6.47 (5-15)	0.16
MMSE	20.63±3.45(13-24)	16.81±4.33(10-24)	0.018
Male/Female (n)	17/17	21/13	0.32
HT (n)	12	26	0.001
HL (n)	14	23	0.028
DM (n)	6	8	0.54
WBC	8.00±1.94 (3.7-12.16)	7.61±1.45 (5.16-11.21)	0.29
Neutrophil	63.26±8.44 (50.2-84.1)	61.91±8.18 (35.8-81.6)	0.44
Lymphocyte	25.81±7.29 (6-35.4)	24.6±7.69 (4.2-42.6)	0.75
NLR	3.01±2.38 (1.57-13.63)	3.28±3.43 (0.84-19.43)	0.92
Hemoglobin	13.09±1.99 (6.4-16.1)	13.49±1.9 (9.2-17)	0.89
Platelet	279.90±95.74 (67-425)	268.25±52.76 (152-461)	0.61
Vitamin D	16.27±6.81 (4.6-29.7)	16.15±9.64 (4.7-35)	0.024

Abbreviations: Fazekas-0: AD subjects without ischemic lesions, Fazekas-3: AD subjects with severe ischemic lesions, MMSE: Mini-mental state examination HT: Hypertension. HL: Hyperlipidemia. DM: Diabetes Mellitus, WBC: White blood cell, NLR: Neutrophil-Lymphocyte ratio